Symbol:
Zc3h12c
Name:
zinc finger CCCH type containing 12C
Description:
Predicted to have endonuclease activity and metal ion binding activity. Orthologous to human ZC3H12C (zinc finger CCCH-type containing 12C); INTERACTS WITH 3,4-methylenedioxymethamphetamine; aflatoxin B1; chloroprene.
Type:
protein-coding
RefSeq Status:
VALIDATED
Also known as:
A230108E06; C230027N18Rik; KIAA1726; mKIAA1726; probable ribonuclease ZC3H12C; zinc finger CCCH domain-containing protein 12C; zinc finger CCCH-type containing 12C
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
ZC3H12C (zinc finger CCCH-type containing 12C) HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Rattus norvegicus (Norway rat):
Zc3h12c (zinc finger CCCH type containing 12C) HGNC
Treefam, EggNOG, NCBI, OMA, HomoloGene, Inparanoid, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Zc3h12c (zinc finger CCCH-type containing 12C) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
ZC3H12C (zinc finger CCCH-type containing 12C) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
ZC3H12C (zinc finger CCCH-type containing 12C) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Zc3h12c (zinc finger CCCH-type containing 12C) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
ZC3H12C (zinc finger CCCH-type containing 12C) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Zc3h12c (zinc finger CCCH type containing 12C)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Homo sapiens (human):
ZC3H12C (zinc finger CCCH-type containing 12C)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Drosophila melanogaster (fruit fly):
CG10889
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Caenorhabditis elegans (roundworm):
rege-1
Alliance
DIOPT (Ensembl Compara, InParanoid, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Latest Assembly:
GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm38 9 52,109,569 - 52,168,730 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 MGSCv37 9 51,920,090 - 51,976,216 (-) NCBI GRCm37 mm9 NCBIm37 MGSCv36 9 51,864,350 - 51,920,476 (-) NCBI mm8 Celera 9 49,387,963 - 49,443,774 (-) NCBI Celera Cytogenetic Map 9 A5.3 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1602083 6480464 2 more ... CTD PMID:23146750 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ZC3H12C mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases methylation EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of ZC3H12C promoter CTD PMID:26251327 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ZC3H12C mRNA CTD PMID:19770486 antirheumatic drug increases expression ISO RGD:1602083 6480464 Antirheumatic Agents results in increased expression of ZC3H12C mRNA CTD PMID:24449571 benzo[e]pyrene decreases methylation ISO RGD:1602083 6480464 benzo(e)pyrene results in decreased methylation of ZC3H12C intron CTD PMID:30157460 bisphenol A increases expression ISO RGD:1565078 6480464 bisphenol A results in increased expression of ZC3H12C mRNA CTD PMID:25181051 calcitriol increases expression ISO RGD:1602083 6480464 Calcitriol results in increased expression of ZC3H12C mRNA CTD PMID:16002434 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of ZC3H12C mRNA CTD PMID:23125180 crocidolite asbestos increases expression ISO RGD:1602083 6480464 Asbestos, Crocidolite results in increased expression of ZC3H12C mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:1602083 6480464 Asbestos, Crocidolite affects the expression of ZC3H12C mRNA CTD PMID:25757056 cyclosporin A increases expression ISO RGD:1602083 6480464 Cyclosporine results in increased expression of ZC3H12C mRNA CTD PMID:20106945 , PMID:25562108 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ZC3H12C mRNA CTD PMID:21266533 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZC3H12C mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1602083 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1602083 6480464 Doxorubicin results in decreased expression of ZC3H12C mRNA CTD PMID:29803840 entinostat decreases expression ISO RGD:1602083 6480464 entinostat results in decreased expression of ZC3H12C mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1602083 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZC3H12C mRNA CTD PMID:27188386 ethyl methanesulfonate increases expression ISO RGD:1602083 6480464 Ethyl Methanesulfonate results in increased expression of ZC3H12C mRNA CTD PMID:23649840 flutamide decreases expression ISO RGD:1565078 6480464 Flutamide results in decreased expression of ZC3H12C mRNA CTD PMID:24793618 formaldehyde increases expression ISO RGD:1602083 6480464 Formaldehyde results in increased expression of ZC3H12C mRNA CTD PMID:23649840 leflunomide increases expression ISO RGD:1602083 6480464 leflunomide results in increased expression of ZC3H12C mRNA CTD PMID:28988120 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of ZC3H12C mRNA CTD PMID:25890327 methapyrilene decreases methylation ISO RGD:1602083 6480464 Methapyrilene results in decreased methylation of ZC3H12C intron CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1602083 6480464 Methyl Methanesulfonate results in increased expression of ZC3H12C mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1602083 6480464 methylmercuric chloride results in decreased expression of ZC3H12C mRNA CTD PMID:28001369 panobinostat decreases expression ISO RGD:1602083 6480464 panobinostat results in decreased expression of ZC3H12C mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1602083 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZC3H12C mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:1602083 6480464 Acetaminophen results in increased expression of ZC3H12C mRNA CTD PMID:29067470 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of ZC3H12C mRNA CTD PMID:19270015 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of ZC3H12C mRNA CTD PMID:23091169 SB 431542 multiple interactions ISO RGD:1602083 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1602083 6480464 Silicon Dioxide analog results in increased expression of ZC3H12C mRNA CTD PMID:25895662 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZC3H12C mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZC3H12C mRNA CTD PMID:21641980 , PMID:26378955 succimer multiple interactions ISO RGD:1602083 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZC3H12C mRNA CTD PMID:26378955 thimerosal increases expression EXP 6480464 Thimerosal results in increased expression of ZC3H12C mRNA CTD PMID:24675092 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of ZC3H12C mRNA CTD PMID:29264374 trichostatin A decreases expression ISO RGD:1602083 6480464 trichostatin A results in decreased expression of ZC3H12C mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1602083 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZC3H12C mRNA CTD PMID:27188386 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of ZC3H12C mRNA CTD PMID:28973697 valproic acid decreases methylation ISO RGD:1602083 6480464 Valproic Acid results in decreased methylation of ZC3H12C gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1565078 6480464 Valproic Acid results in decreased expression of ZC3H12C mRNA CTD PMID:29427782 valproic acid affects expression ISO RGD:1602083 6480464 Valproic Acid affects the expression of ZC3H12C mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1602083 6480464 Valproic Acid results in decreased expression of ZC3H12C mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1602083 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZC3H12C mRNA CTD PMID:27188386 zoledronic acid increases expression ISO RGD:1602083 6480464 zoledronic acid results in increased expression of ZC3H12C mRNA CTD PMID:24714768 
Gene-Chemical Interaction Annotations
